Your session is about to expire
← Back to Search
GPS Exploration for Depression
N/A
Recruiting
Led By Aaron S Heller, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Must not have
Severe/unstable medical conditions
History of head trauma, seizures, or neurological disorders
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial explores how our environment, thoughts, emotions, and brain activity are connected, using smartphones to collect data.
Who is the study for?
This trial is for individuals willing to share emotional and cognitive data via smartphone, including using a GPS tracking app for four months. They must consent to an FMRI scan and respond to daily texts about their emotions. It's not suitable for those with head trauma, neurological disorders, severe medical conditions, pregnancy, or history of severe substance abuse.
What is being tested?
The study aims to understand the relationship between real-world behaviors, thoughts, emotions, and brain activity by monitoring participants through smartphone technology that tracks location and captures emotional responses.
What are the potential side effects?
There are no direct side effects from the interventions being studied as they involve non-invasive tracking of participant's locations and emotions using smartphones and responding to text messages.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have any severe or unstable health conditions.
Select...
I have a history of head injuries, seizures, or neurological issues.
Select...
I am taking medication for a psychiatric condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in positive emotional response as measured by ecological momentary assessment
Secondary study objectives
Change in negative emotional response as measured by ecological momentary assessment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Modifying ExplorationExperimental Treatment1 Intervention
Individuals will be asked on certain days to increase their levels of exploration, and some days be asked to decrease their levels of exploration. Participants will do this for up to six months.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
955 Previous Clinical Trials
428,748 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,936 Previous Clinical Trials
2,751,541 Total Patients Enrolled
20 Trials studying Anhedonia
1,901 Patients Enrolled for Anhedonia
Aaron S Heller, PhDPrincipal InvestigatorUniversity of Miami
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have medical conditions that make it difficult to have an MRI scan.I do not have any severe or unstable health conditions.I am willing to use a GPS tracking app on my phone for four months.You have a serious problem with using drugs or alcohol.You have ever been diagnosed with a psychotic or bipolar disorder.I have a history of head injuries, seizures, or neurological issues.I am taking medication for a psychiatric condition.
Research Study Groups:
This trial has the following groups:- Group 1: Modifying Exploration
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.